Phase Scientific International (PSI), a Hong Kong medical diagnostic products maker, has automated a key Covid-19 testing process, allowing it to improve the speed and reliability of the tests. It has also entered into an exclusive partnership with a local laboratory to offer the tests at a much lower cost.
PSI said that ONCO Medical Laboratory, which last week was added to the list of laboratories recognised by the Hong Kong government for nucleic acid Covid-19 testing, will only use the company’s products for these tests.
“Through this collaboration … we are now involved in serving end users in the local market,” said Ricky Chiu Yin-to, founder and CEO of PSI.